Mayo Clinic
Mayo Clinic Laboratories, Helix Collaborate to Offer Biopharma Lab Services
The partnership makes Mayo's tests and pathology services and Helix's Exome+ assay available to biopharma customers.
Team Untangles Mechanism Behind Noncoding Glioma Risk Variant
A SNP on chromosome 8 that increases risk of IDH-mutant low-grade glioma falls in a brain-specific enhancer that alters transcription factor binding and downstream signaling.
Genomadix, Mayo Clinic Collaborate on Point-of-Care PCR
The deal is intended to advance the firm's portable PCR-based diagnostics system, called the Cube, which generates results in approximately one hour.
Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium
Several institutions, swayed by PGx experts and advocates, are setting up DPYD testing to avoid deadly chemo toxicities in patients even though the NCCN and FDA don't back it.
Biotia Joins Mayo Clinic Program for AI Startups
The firm will focus on validating its next-generation sequencing-based microbial surveillance service and readying it for clinical use.